Evidence map›Paper›PMID 24911490›Full record

ArticleNature biotechnology2014

The International Cancer Genome Consortium's evolving data-protection policies.

Djims Milius, Edward S Dove, Donald Chalmers, Stephanie O M Dyke, Kazuto Kato, Pilar Nicolás, B F Francis Ouellette, Brad Ozenberger, Laura L Rodriguez, Nikolajs Zeps and 1 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Djims MiliusCentre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.
Edward S DoveCentre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.
Donald ChalmersFaculty of Law, University of Tasmania, Tasmania, Australia.
Stephanie O M DykeWellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Kazuto KatoDepartment of Biomedical Ethics and Public Policy, Graduate School of Medicine, Osaka University, Osaka, Japan.
Pilar NicolásInteruniversity Chair in Law and the Human Genome, Universidad de Deusto, Universidad del País Vasco, Bilbao, Spain.
B F Francis Ouellette1] Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Canada. [2] Department of Cell and Systems Biology, University of Toronto, Toronto, Canada.
Brad OzenbergerNational Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Laura L RodriguezNational Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nikolajs ZepsSchool of Pathology and Laboratory Medicine, The University of Western Australia, Crawley, Western Australia, Australia.
Yann JolyCentre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Computer SecurityOrganizational PolicyForecastingGenetic PrivacyGeneticsGenetics, MedicalGenomicsInternational AgenciesMedical OncologySocieties

Identifiers

PMID24911490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.